1. The Anticancer Effect of a Flavonoid-Rich Extract of Bergamot Juice in THP-1 Cells Engages the SIRT2/AKT/p53 Pathway
   Alessandro Maugeri et al, 2022, Pharmaceutics CrossRef
2. Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway
   Theresa Grohmann et al, 2018, Leukemia Research CrossRef
3. Structure activity study of S-trityl-cysteamine dimethylaminopyridine derivatives as SIRT2 inhibitors: Improvement of SIRT2 binding and inhibition
   Mohamed O. Radwan et al, 2020, Bioorganic & Medicinal Chemistry Letters CrossRef
4. Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies
   Zsuzsanna Gaál, 2022, Biomolecules CrossRef
5. Silencing thePIK3CAGene Enhances the Sensitivity of Childhood Leukemia Cells to Chemotherapy Drugs by Suppressing the Phosphorylation of Akt
   Xiuling Liang et al, 2019, Yonsei Medical Journal CrossRef
6. SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia
   Ailing Deng et al, 2016, Scientific Reports CrossRef
7. ATG5 regulates mesenchymal stem cells differentiation and mediates chemosensitivity in acute myeloid leukemia
   Ying Li et al, 2020, Biochemical and Biophysical Research Communications CrossRef
8. Sirtuin2 enhances the tumoricidal function of liver natural killer cells in a mouse hepatocellular carcinoma model
   Ming Chen et al, 2019, Cancer Immunology, Immunotherapy CrossRef
9. Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma
   Tianling Ding et al, 2021, Molecular Medicine Reports CrossRef
10. Sirtuins in hematopoiesis and blood malignancies
    Berta N. Vazquez et al, 2021, Sirtuin Biology in Medicine CrossRef
11. Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines
    María Paula Ceballos et al, 2018, Toxicology Letters CrossRef
12. Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer
    Li-yuan Feng et al, 2020, Journal of Ovarian Research CrossRef
13. Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines
    Tomohiro Kozako et al, 2018, BMC Cancer CrossRef
14. Long noncoding RNA SNHG1 predicts poor prognosis and facilitates disease progression in acute myeloid leukemia
    Ming Tian et al, 2019, Biology Open CrossRef
15. Epigenetics in acute myeloid leukemia
    Carmela Dell’Aversana et al, 2021, Medical Epigenetics CrossRef
16. Sirtinol Supresses Trophozoites Proliferation and Encystation of Acanthamoeba via Inhibition of Sirtuin Family Protein
    So-Young Joo et al, 2022, The Korean Journal of Parasitology CrossRef
17. Insulin Deficiency Increases Sirt2 Level in Streptozotocin-Treated Alzheimer’s Disease-Like Mouse Model: Increased Sirt2 Induces Tau Phosphorylation Through ERK Activation
    Chunyu Zhou et al, 2022, Molecular Neurobiology CrossRef
18. The role of SIRT2 in cancer: A novel therapeutic target
    Guangyuan Chen et al, 2020, International Journal of Cancer CrossRef
19. Emerging role of SIRT2 in non-small cell lung cancer (Review)
    Mengge Zheng et al, 2021, Oncology Letters CrossRef
20. Sirtuin 2 promotes cell stemness and MEK/ERK signaling pathway while reduces chemosensitivity in endometrial cancer
    Nannan Zhao et al, 2022, Archives of Gynecology and Obstetrics CrossRef
21. Treatment Failure in Acute Myeloid Leukemia: Focus on the Role of Extracellular Vesicles
    Reza Mirfakhraie et al, 2022, Leukemia Research CrossRef
22. Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure–Activity Relationship, X-ray Crystal Structure, and Anticancer Activity
    Sébastien Moniot et al, 2017, Journal of Medicinal Chemistry CrossRef
23. Recent advances in the development of histone deacylase SIRT2 inhibitors
    Wenyu Yang et al, 2020, RSC Advances CrossRef
24. A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms
    Laura Locatelli et al, 2021, Current Issues in Molecular Biology CrossRef